We are live on ! Find out more
BIND

BIND THERAPEUTICS INC
BIND

Delisted

BIND was delisted on the 29th of July, 2016.

Back to rankings

38 hedge funds and large institutions have $9.14M invested in BIND THERAPEUTICS INC in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

13,050% more call options, than puts

Call options by funds: $263K | Put options by funds: $2K

100% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 4

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

15% more funds holding

Funds holding: 33 → 38 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

45% less capital invested

Capital invested by funds: $16.7M → $9.14M (-$7.51M)

Holders
38
Holders Change
+5
Holders Change %
+15.15%
% of All Funds
1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
11
Increased
8
Reduced
4
Closed
6
Calls
$263K
Puts
$2K
Net Calls
+$261K
Net Calls Change
-$255K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$503K
2
SIM
Spark Investment Management
New York
+$149K
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$134K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$129K
5
BCM
Bridgeway Capital Management
Texas
+$121K

Top Sellers

Rank Fund Capital Flow
1
FMA
FNY Managed Accounts
New York
-$134K
2
PCM
Prelude Capital Management
New York
-$116K
3
Millennium Management
Millennium Management
New York
-$109K
4
Morgan Stanley
Morgan Stanley
New York
-$73.1K
5
Stifel Financial
Stifel Financial
Missouri
-$64K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$7K -$760 -188 -6%
Citigroup
27
Citigroup
New York
$6K -$11.8K -2,910 -51%
BIM
28
BlackRock Investment Management
Delaware
$6K +$816 +202 +8%
PNC Financial Services Group
29
PNC Financial Services Group
Pennsylvania
$5K – – –
Creative Planning
30
Creative Planning
Kansas
$5K +$8.08K +2,000 New
Wells Fargo
31
Wells Fargo
California
$4K – – –
CG
32
Cutler Group
California
$2K +$4.04K +1,000 New
GBBWRPM
33
Genovese Burford & Brothers Wealth & Retirement Plan Management
California
$2K +$4.04K +1,000 New
TRCT
34
Tower Research Capital (TRC)
New York
$1K +$1.21K +300 New
Manulife (Manufacturers Life Insurance)
35
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2 – – –
FMA
36
FNY Managed Accounts
New York
– -$134K -30,000 Closed
PCM
37
Prelude Capital Management
New York
– -$116K -26,000 Closed
Millennium Management
38
Millennium Management
New York
– -$109K -24,500 Closed
OC
39
Oppenheimer & Co
New York
– -$46K -10,500 Closed
TDC
40
Thompson Davis & Co
Virginia
– -$20K -4,500 Closed
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
– -$3K -764 Closed
1
2

BIND Hedge Fund Activity: Q4 2015 in Review

38 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in BIND THERAPEUTICS INC (BIND) for Q4 2015, worth a combined $9.14M — down 45% from $16.7M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new BIND positions and 6 closed out — a net gain of 5 holders — while 8 added to existing stakes and 4 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $503K. The largest seller was FNY Managed Accounts, exiting entirely with an estimated $134K sold.

  • 38 institutional investors held BIND THERAPEUTICS INC (BIND) as of Q4 2015, up from 33 in Q3 2015.
  • Funds reported $9.14M of BIND THERAPEUTICS INC stock for Q4 2015, down 45% quarter-over-quarter.
  • 11 funds opened new BIND THERAPEUTICS INC positions in Q4 2015 and 6 closed out, a net change of +5 holders.
  • The largest BIND THERAPEUTICS INC buyer in Q4 2015 was Renaissance Technologies, an estimated $503K added.
  • The largest BIND THERAPEUTICS INC seller in Q4 2015 was FNY Managed Accounts, an estimated $134K sold.

Based on aggregated 13F filings for Q4 2015.